These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 26999331)

  • 41. Attenuation of the DNA damage response by transforming growth factor-beta inhibitors enhances radiation sensitivity of non-small-cell lung cancer cells in vitro and in vivo.
    Du S; Bouquet S; Lo CH; Pellicciotta I; Bolourchi S; Parry R; Barcellos-Hoff MH
    Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):91-9. PubMed ID: 25835621
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of mTOR activity restores tamoxifen response in breast cancer cells with aberrant Akt Activity.
    deGraffenried LA; Friedrichs WE; Russell DH; Donzis EJ; Middleton AK; Silva JM; Roth RA; Hidalgo M
    Clin Cancer Res; 2004 Dec; 10(23):8059-67. PubMed ID: 15585641
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Preliminary study on radiosensitivity to carbon ions in human breast cancer.
    Zhang Q; Kong Y; Yang Z; Liu Y; Liu R; Geng Y; Luo H; Zhang H; Li H; Feng S; Wang X
    J Radiat Res; 2020 May; 61(3):399-409. PubMed ID: 32239160
    [TBL] [Abstract][Full Text] [Related]  

  • 44. LKB1 gene inactivation does not sensitize non-small cell lung cancer cells to mTOR inhibitors in vitro.
    Xiao P; Sun LL; Wang J; Han RL; Ma Q; Zhong DS
    Acta Pharmacol Sin; 2015 Sep; 36(9):1107-12. PubMed ID: 26027660
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bone morphogenetic protein-2-induced transformation involves the activation of mammalian target of rapamycin.
    Langenfeld EM; Kong Y; Langenfeld J
    Mol Cancer Res; 2005 Dec; 3(12):679-84. PubMed ID: 16380505
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Radio-sensitization effect of an mTOR inhibitor, temsirolimus, on lung adenocarcinoma A549 cells under normoxic and hypoxic conditions.
    Ushijima H; Suzuki Y; Oike T; Komachi M; Yoshimoto Y; Ando K; Okonogi N; Sato H; Noda SE; Saito J; Nakano T
    J Radiat Res; 2015 Jul; 56(4):663-8. PubMed ID: 25887043
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of mTOR sensitizes breast cancer stem cells to radiation-induced repression of self-renewal through the regulation of MnSOD and Akt.
    Lai Y; Yu X; Lin X; He S
    Int J Mol Med; 2016 Feb; 37(2):369-77. PubMed ID: 26707081
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Huachansu, containing cardiac glycosides, enhances radiosensitivity of human lung cancer cells.
    Wang L; Raju U; Milas L; Molkentine D; Zhang Z; Yang P; Cohen L; Meng Z; Liao Z
    Anticancer Res; 2011 Jun; 31(6):2141-8. PubMed ID: 21737634
    [TBL] [Abstract][Full Text] [Related]  

  • 49. NVP-BEZ235, dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor, prominently enhances radiosensitivity of prostate cancer cell line PC-3.
    Zhu W; Fu W; Hu L
    Cancer Biother Radiopharm; 2013 Nov; 28(9):665-73. PubMed ID: 23768063
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Piperlongumine induces apoptosis and autophagy in human lung cancer cells through inhibition of PI3K/Akt/mTOR pathway.
    Wang F; Mao Y; You Q; Hua D; Cai D
    Int J Immunopathol Pharmacol; 2015 Sep; 28(3):362-73. PubMed ID: 26246196
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Role of AMP-activated protein kinase activators in antiproliferative multi-drug pituitary tumour therapies: effects of combined treatments with compounds affecting the mTOR-p70S6 kinase axis in cultured pituitary tumour cells.
    Tulipano G; Faggi L; Cacciamali A; Spinello M; Cocchi D; Giustina A
    J Neuroendocrinol; 2015 Jan; 27(1):20-32. PubMed ID: 25323047
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Targeting PI3K/Akt/mTOR signaling pathway in the treatment of prostate cancer radioresistance.
    Chang L; Graham PH; Ni J; Hao J; Bucci J; Cozzi PJ; Li Y
    Crit Rev Oncol Hematol; 2015 Dec; 96(3):507-17. PubMed ID: 26253360
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of rapamycin on cell proliferation and phosphorylation of mTOR and p70(S6K) in HepG2 and HepG2 cells overexpressing constitutively active Akt/PKB.
    Varma S; Khandelwal RL
    Biochim Biophys Acta; 2007 Jan; 1770(1):71-8. PubMed ID: 16952420
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Histone deacetylase inhibitor NVP-LAQ824 sensitizes human nonsmall cell lung cancer to the cytotoxic effects of ionizing radiation.
    Cuneo KC; Fu A; Osusky K; Huamani J; Hallahan DE; Geng L
    Anticancer Drugs; 2007 Aug; 18(7):793-800. PubMed ID: 17581301
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CWF-145, a novel synthetic quinolone derivative exerts potent antimitotic activity against human prostate cancer: Rapamycin enhances antimitotic drug-induced apoptosis through the inhibition of Akt/mTOR pathway.
    Hung CM; Lin YC; Liu LC; Kuo SC; Ho CT; Way TD
    Chem Biol Interact; 2016 Dec; 260():1-12. PubMed ID: 27769712
    [TBL] [Abstract][Full Text] [Related]  

  • 56. mTOR inhibitors sensitize thyroid cancer cells to cytotoxic effect of vemurafenib.
    Hanly EK; Bednarczyk RB; Tuli NY; Moscatello AL; Halicka HD; Li J; Geliebter J; Darzynkiewicz Z; Tiwari RK
    Oncotarget; 2015 Nov; 6(37):39702-13. PubMed ID: 26284586
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enhancement of radiation-induced DNA damage and inhibition of its repair by a novel camptothecin analog.
    Huang G; Wang H; Yang LX
    Anticancer Res; 2010 Mar; 30(3):937-44. PubMed ID: 20393017
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combined inhibition of the EGFR and mTOR pathways in EGFR wild-type non-small cell lung cancer cell lines with different genetic backgrounds.
    Huang Y; Chen Y; Mei Q; Chen Y; Yu S; Xia S
    Oncol Rep; 2013 Jun; 29(6):2486-92. PubMed ID: 23525575
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metformin enhances the radiosensitivity of human liver cancer cells to γ-rays and carbon ion beams.
    Kim EH; Kim MS; Furusawa Y; Uzawa A; Han S; Jung WG; Sai S
    Oncotarget; 2016 Dec; 7(49):80568-80578. PubMed ID: 27802188
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MHY1485 enhances X-irradiation-induced apoptosis and senescence in tumor cells.
    Sun L; Morikawa K; Sogo Y; Sugiura Y
    J Radiat Res; 2021 Sep; 62(5):782-792. PubMed ID: 34265852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.